Scott W. Andersen

Donanemab in Early Alzheimer’s Disease

Mark A. Mintun, Albert Lo, Cynthia Evans et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders

Pierre V. Trân, S.H. Hamilton, Amy J. Kuntz et al. · Journal of Clinical Psychopharmacology · 1997 · 717 citations

Other Psychotic Disorders, Neuropsychology, Psychotropic Medication +19

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Stephen Salloway, Martin R. Farlow, Eric McDade et al. · Nature Medicine · 2021 · 349 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Alzheimer's Disease +9

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

Alette M. Wessels, Pierre N. Tariot, Jennifer A. Zimmer et al. · JAMA Neurology · 2019 · 191 citations · Full text

Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes

Sergey Shcherbinin, Cynthia Evans, Ming‐Chi Lu et al. · JAMA Neurology · 2022 · 175 citations · Full text